Effectiveness of fluvoxamine at preventing COVID-19 infection from turning severe

被引：3
|
作者：
Boretti, Alberto [1 ]
机构：
[1] Johnsonville Rd, Wellington 6037, New Zealand
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2023年 / 67卷
关键词：
D O I：
10.1016/j.euroneuro.2022.12.001
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：83 / 85
页数：3
相关论文
共 50 条
  • [1] Effectiveness of booster BCG vaccination in preventing Covid-19 infection
    Amirlak, Lradj
    Haddad, Rifat
    Hardy, John Denis
    Khaled, Naief Suleiman
    Chung, Michael H.
    Amirlak, Bardia
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 3913 - 3915
  • [2] Fluvoxamine for COVID-19?
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1623): : 69 - 70
  • [3] Fluvoxamine in COVID-19
    Devi, Sharmila
    LANCET INFECTIOUS DISEASES, 2024, 24 (01) : E23 - E23
  • [4] Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant
    O'Horo, John C.
    Challener, Douglas W.
    Speicher, Leigh
    Bosch, Wendelyn
    Seville, Maria Teresa
    Bierle, Dennis M.
    Ganesh, Ravindra
    Wilker, Caroline G.
    Arndt, Richard F.
    Arndt, Lori L.
    Tulledge-Scheitel, Sidna M.
    Hanson, Sara N.
    Razonable, Raymund R.
    MAYO CLINIC PROCEEDINGS, 2022, 97 (02) : 327 - 332
  • [5] Fluvoxamine for the treatment of COVID-19
    Kim, Hyun
    Manzi, Shannon
    Gonzelez-Heydrich, Joseph
    Picker, Jonathan
    LANCET GLOBAL HEALTH, 2022, 10 (03): : E330 - E330
  • [6] Fluvoxamine for the treatment of COVID-19
    Nyirenda, John L. Z.
    Sofroniou, Mario
    Toews, Ingrid
    Mikolajewska, Agata
    Lehane, Cornelius
    Monsef, Ina
    Abu-taha, Aesha
    Maun, Andy
    Stegemann, Miriam
    Schmucker, Christine
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (09):
  • [7] Trial of fluvoxamine in COVID-19
    Kang, Seema
    LANCET PSYCHIATRY, 2022, 9 (01): : 17 - 17
  • [8] Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomes
    Samah Hayek
    Yatir Ben-shlomo
    Noa Dagan
    Ben Y. Reis
    Noam Barda
    Eldad Kepten
    Alina Roitman
    Shachar Shapira
    Shlomit Yaron
    Ran D. Balicer
    Doron Netzer
    Alon Peretz
    Nature Communications, 13
  • [9] Effectiveness of Vaccines and Antiviral Drugs in Preventing Severe and Fatal COVID-19, Hong Kong
    Cheung, Yue Yat Harrison
    Lau, Eric Ho Yin
    Yin, Guosheng
    Lin, Yun
    Cowling, Benjamin J.
    Lam, Kwok Fai
    EMERGING INFECTIOUS DISEASES, 2024, 30 (01) : 70 - 78
  • [10] Fluvoxamine, melatonin and COVID-19
    George M. Anderson
    Psychopharmacology, 2021, 238 : 611 - 611
12345